Dominique Costantini
Founder at OSE IMMUNOTHERAPEUTICS
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Anne-Laure Autret-Cornet | F | - | 8 years | |
Nicolas Poirier | M | 42 | 8 years | |
Maryvonne Hiance | F | 75 | 8 years | |
Corinna Zur Bonsen-Thomas | M | - | 7 years | |
Jérôme Martinez | M | 63 | 6 years | |
Didier Blondel | M | - | 7 years | |
Alice Nolla | F | - |
Only For Children Pharmaceuticals SA
| - |
Karine Rossignol | M | - |
Smart Immune SAS
Smart Immune SAS BiotechnologyHealth Technology Smart Immune SAS is a clinical-stage biotechnology company based in Paris, France. Smart Immune is developing Protcell, a thymus-empowered T cell progenitor therapy platform to re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The French company aims to improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the EU and the US. Smart101 is already in phase I/II clinical trials in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its Protcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The company is headquartered at Biotech Santé. The company was founded in 2017 by Karine Rossignol, Marina Cavazzana, Isabelle André, with Karine Rossignol as the CEO since 2017. | 7 years |
Eric Doulat | M | - | 4 years | |
Laurence de Schoulepnikoff | F | - | 3 years | |
Elsy Boglioli Hofman | F | 42 | 3 years | |
Eric Jean Marie Leire | M | 66 | 1 years | |
Brigitte Dreno | M | 71 | 7 years | |
Fouzia Laghrissi-Thodes | M | 61 |
Smart Immune SAS
Smart Immune SAS BiotechnologyHealth Technology Smart Immune SAS is a clinical-stage biotechnology company based in Paris, France. Smart Immune is developing Protcell, a thymus-empowered T cell progenitor therapy platform to re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The French company aims to improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the EU and the US. Smart101 is already in phase I/II clinical trials in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its Protcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The company is headquartered at Biotech Santé. The company was founded in 2017 by Karine Rossignol, Marina Cavazzana, Isabelle André, with Karine Rossignol as the CEO since 2017. | - |
Gérard Tobelem | M | 76 | 10 years | |
Jean Nicolas Trebouta | M | 61 | 13 years | |
Didier Hoch | M | 68 | 8 years | |
Alexandre LeBeaut | M | 66 | 2 years | |
Carol Brosgart | M | 72 | 6 years | |
Sylvie Détry | F | - | - | |
Vincent Grek | M | - |
Only For Children Pharmaceuticals SA
| - |
Sophie Fay | F | - | - | |
Francoise Vincent-Larrode | M | - | 6 years | |
Nicolas Mottis | M | - |
Only For Children Pharmaceuticals SA
| - |
Thomas Guillot | M | - | - | |
Silvia Comis | M | - | 3 years | |
Françoise Bono | M | - | 3 years | |
Jean-Pascal Conduzorgues | M | - | - | |
Estelle Habert-Ortoli | F | - |
Only For Children Pharmaceuticals SA
| - |
Linda Lebon | F | 58 | 3 years | |
Jean Jacques Mention | M | - | - |
Connections Chart
Multi-company connection
Former connections
Statistics
Country | Connections | % of total |
---|---|---|
France | 80 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dominique Costantini
- Personal Network